Report cover image

The Market and Potential for CRISPR/Cas9 Gene Editing

Publisher Kalorama Information
Published Feb 05, 2018
Length 101 Pages
SKU # KLI15596715

Description

The Market and Potential for CRISPR/Cas9 Gene Editing 

 This report consolidates the information and trends and provides reliable market estimates for CRISPR technology to 2023. As part of the report's coverage, it provides the following:

  • Market Size and Forecast for CRISPR/Cas9 Gene Editing, 2017-2023 
  • The Market for CRISPR/Cas9 by Region (N. Amer. EU, ROW), 2017-2023 Analysis of Growth Trend by Region
  • Market by Application (Cancer Research, Non-Cancer Disease Research, Cancer Diagnostics, Infection Diagnostics, Plant, Food, Biofuel, Drug Discovery, Drug Development, Other) 
  • Growth Trend, U.S.
  • Growth Trend, Outside U.S. 
  • Market by End User (Hospitals, University, Medical Research Institute, Government), 2017 
  • Market by End User (Hospitals, University, Medical Research Institute, Government), 2023 
  • Recent Technology and Market Developments and Medical Studies
  • Partnerships Involving CRISPR Gene Editing

Companies in the Market and Partnerships in Gene Editing

In 2018, more than 30 players participate in this market, from large multinational corporations to small, niche life sciences companies.  Key players include Agilent, MilliporeSigma, GE Healthcare Dharmcon, GeneScript, Horizon Discovery Group, OriGene, ThermoFisher Scientific, Transposagen, and ToolGen. These companies develop and commercialize various products and services for each of the major gene editing technologies.  

The nature of CRISPR’s complex technology requires partnerships between the developers of the technology and the healthcare concerns with distribution strength and a broader product base. These developments are outlined in the report.

Recent Lawsuit and Industry Risk Analysis 

Currently, one of the more significant factors in commercializing CRISPR-Cas9 as a viable therapeutic tool is the current legal battles surrounding the technology. The issue started when both the University of California, Berkeley (UCB) and the Broad Institute of MIT (the Broad) both filed patents related to this technology. While there's been some resolution, the report provides an analysis of developments. 
 

Table of Contents

101 Pages
    • Overview
    • NIH Grants for CRISPR Projects
    • Industry Risk Analysis - Patent Landscape
    • Other Recent CRISPR/Cas9 Developments
    • The Market for CRISPR Equipment and Supplies
    • Trends in Gene Editing
    • Significant Partnerships in Gene Editing
    • Overview
    • Recent Applications and Developments
    • Companies in CRISPR Gene Editing
    • Commercial Applications of Gene Editing Technologies
    • Using CRISPR for Diagnostics
    • Using CRISPR for Human Therapeutics
    • CRISPR Companies
    • Market Analysis Commentary
    • The Market for CRISPR Equipment and Supplies
    • Growth Trend
    • Market by Application
    • Market by End User
    • Caribou Biosciences, Inc.
    • Sangamo Biosciences
    • CRISPR Therapeutics
    • Editas Medicine
    • Intellia Therapeutics
    • Precision Biosciences
    • BlueBird Biotechnologies
    • Christiana Care's Gene Editing Institute
    • Casebia Therapeutics
    • Synthego
    • Sarepta Therapeutics
    • Homology Medicines
    • GenScript
    • Cellectis, Inc.
    • Merck
    • Twist Bioscience, Desktop Genetics
    • AstraZeneca
    • Increasing Investments and Funding in Gene Editing Area to Augment Market Revenues

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us